Physician profile
Robert M Welsh
NPI 1518935618
$738.59
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.88 · 2022: $140 · 2023: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $137.00 | 2022-2023 | |
| Kowa Pharmaceuticals America, INC. | $129.94 | 2023 | Seglentis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.48 | 2022-2023 | Relistor |
| Idorsia Pharmaceuticals US INC | $67.09 | 2023 | Quviviq |
| Radius Health, INC. | $64.08 | 2022-2023 | Tymlos |
| Abbott Laboratories | $59.28 | 2021-2023 | Proclaim |
| Pfizer INC. | $56.78 | 2023 | |
| Bioventus LLC | $27.14 | 2023 | Durolane |
| Vbi Vaccine (Delaware) INC. | $26.95 | 2022 | |
| Nalu Medical, INC. | $24.00 | 2023 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $20.30 | 2023 | Xtampza |
| Amgen INC. | $18.00 | 2022 | |
| Tersera Therapeutics LLC | $16.53 | 2023 | Prialt |
| Lilly USA, LLC | $16.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Welsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.